[ad_1]
People who are on weight-loss journeys ought to not rely solely on anti-obesity medications, based on an announcement from a nationwide vitamin affiliation.
The Academy of Nutrition and Dietetics launched the assertion on March 4, which is World Obesity Day.
“The academy calls on the medical community, including pharmaceutical manufacturers of anti-obesity medications, obesity medicine providers and other health care practitioners specializing in obesity, to enhance the efficacy of these medications and maximize patient success rates by including a referral for medical nutrition therapy from a registered dietitian nutritionist alongside prescriptions for anti-obesity medications,” stated Dr. Lauri Wright, PhD, president of the Chicago-based academy.
“The anti-obesity medications alone will not end obesity unless they are combined with a collaborative, interprofessional approach that includes policy changes to reduce health inequity and disparity,” she additionally stated within the launch.
In an announcement to Fox News Digital, Wright emphasised the necessity to overcome obstacles to weight problems remedy.
“We must reevaluate how we treat and prevent obesity by increasing access to nutritious food and for health insurance plans to cover nutrition services,” she stated.
“Medical nutrition therapy and intensive behavioral therapy provided by a registered dietitian nutritionist are both proven and cost-effective.”
Semaglutides, a category of medications often called GLP-1 receptor agonists — together with Ozempic (prescribed for diabetes administration), Wegovy (prescribed for weight reduction), Rybelsus (kind 2 diabetes) and Saxenda (weight reduction) — have been spiking in reputation lately.
The variety of folks within the U.S. utilizing GLP-1 agonists for both diabetes or weight problems reached 40 million in 2022, analysis has proven.
In the academy’s assertion, Wright referred to weight problems as “a complex, chronic and progressive disease associated with serious complications and risk of mortality.”
“Recognizing World Obesity Day during National Nutrition Month is an opportunity to reevaluate how we best utilize anti-obesity medications to ensure that every patient has access to both lifestyle interventions and safe and effective medications that can improve the health of many adults in the U.S.,” she added.
The academy stated it plans to launch a white paper within the spring, which could have detailed suggestions for way of life interventions.
Doctors share ideas on the academy’s stance
Dr. Marc Siegel, medical professor of medication at NYU Langone Medical Center and a Fox News medical contributor, responded to the assertion in a dialog with Fox News Digital.
“It is important that we put a spotlight on this huge burgeoning problem during World Obesity Day,” he stated.
OZEMPIC, THE HAPPY DRUG? STUDY SUGGESTS WEIGHT-LOSS MEDICATIONS COULD REDUCE DEPRESSION, ANXIETY
“With over one billion overweight folks on the earth and over a 40% weight problems price within the U.S., we now have an enormous downside.”
While Siegel is in settlement with the academy’s stance, he famous that not everybody with weight problems must be on a weight-loss medicine.
“The Academy of Nutrition and Dietetics is right to spotlight this, but wrong to imply that this shifting focus needs to include a prescription for an anti-obesity medication, presumably a semaglutide (Ozempic, Wegovy) or a tirzepatide (Mounjaro, Zepbound).”
Given the “tremendous shortage” of those medication, Siegel warned that many diabetics who want them cannot get them.
“And at the same time, not everyone tolerates them well, and we don’t have a complete handle yet on long-term side effects,” the physician famous.
VIBRATING WEIGHT LOSS PILL COULD PROVIDE ALTERNATIVE TO OZEMPIC AND WEGOVY, RESEARCHERS SAY
“I certainly think they are useful — and can think of many situations where they decrease risks of heart disease, stroke, diabetes and cancer as well as the need for bariatric surgery — but they are surely not one size fits all and are mostly not first-line therapy.”
To promote wholesome weight administration, Siegel advisable rising each day train and adopting a weight loss program wealthy in greens and fiber and decrease in “empty calories.”
“With over one billion obese people in the world and over a 40% obesity rate in the U.S., we have a huge problem.”
Dr. Brett Osborn, a Florida neurologist and longevity professional, is an enormous proponent of semaglutide medications as a “highly potent” remedy within the struggle in opposition to weight problems.
“They are indeed the holy grail of modern-day medicine and will likely have a similar effect on worldwide health as the advent of antibiotics in the early 1900s,” he predicted to Fox News Digital.
CLICK HERE TO GET THE FOX NEWS APP
Osborn stated he agrees with the academy’s suggestion.
“The management of obesity is complex,” he advised Fox News Digital. “It is best done through a multi-pronged approach that emphasizes proper nutrition, exercise and psychosocial factors. One cannot anticipate long-term and sustainable results without all three.”
Medications like Ozempic and Mounjaro have “changed the landscape of obesity management,” Osborn stated.
“By sending a robust satiety signal to the brain, these medications force the brain to ‘just say no,’ equating to a caloric deficit and weight loss,” he stated.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“But absent exercise and a properly designed macronutrient-based food regimen with its full complement of protein, fats and carbohydrates, one may develop a relatively malnourished state … and a compromised immune system.”
For this purpose, Osborn advisable that medications like Ozempic and Mounjaro ought to all the time be prescribed together with vitamin and train counseling.
Fox News Digital reached out to Novo Nordisk, maker of Ozempic and Wegovy, for remark.
For extra Health articles, go to www.foxnews.com/well being.
[ad_2]
Source hyperlink